Cara Therapeutics | Zysk Brutto



Pre Tax Profit Zmiana Data
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Cassava Sciences USD -27597000 346K 2024-12
Chugai Pharma JPY 135.83B 10.32B 2025-03
Cipla INR 15.04B 4.12B 2025-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6113000 11.89M 2024-12
CSL USD 2.54B 1.34B 2024-12
Grifols 66.98M 19.92M 2024-06
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
J&J USD 13.63B 8.21B 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Pacira USD 8.71M 16.82M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
RedHill Biopharma USD -1540000 12M 2024-06
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12



Cara Therapeutics Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.